Back to Search
RISHI PURI, MD, PHD
MD, PHD
Interventional Cardiology Physician
NPI: 1821570128IndividualAccepts Medicare
Specialties, Licenses & Credentials
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
75.000017(OH)
CMS Specialties
PrimaryINTERVENTIONAL CARDIOLOGY
Education
OTHER
Class of 2001
Research & Publications (20)
Gross echocardiographic underestimation of mitral valve calcification--a near fatal experience.
PMID 19136163·Int J Cardiol·2010
5-case
Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease.
PMID 19542233·J Biol Chem·2009
7-preclinical
IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma.
PMID 19065664·Int J Cancer·2009
7-preclinical
Response of multiple recurrent TaT1 bladder cancer to intravesical apaziquone (EO9): comparative analysis of tumor recurrence rates.
PMID 19232688·Urology·2009
4-observational
Randomized controlled trial of endoscopic ultrasound-guided fine-needle sampling with or without suction for better cytological diagnosis.
PMID 19117242·Scand J Gastroenterol·2009
2-rct
A review of gene expression profiling of human embryonic stem cell lines and their differentiated progeny.
PMID 19442194·Curr Stem Cell Res Ther·2009
6-review
The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system.
PMID 19036738·Hum Mol Genet·2009
7-preclinical
Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.
PMID 19491224·J Clin Endocrinol Metab·2009
7-preclinical
Mannosylated self-assembled structures for molecular confinement and gene delivery applications.
PMID 19032946·Biochem Biophys Res Commun·2009
7-preclinical
Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer.
PMID 19214526·World J Urol·2009
3-trial
Highly selective potentiometric determination of mercury(II) ions using 1-furan-2-yl-4-(4-nitrophenyl)-2-phenyl-5H-imidazole-3-oxide based membrane electrodes.
PMID 19185990·J Hazard Mater·2009
8-other
Identification of potential therapeutic targets in human head & neck squamous cell carcinoma.
PMID 19602232·Head Neck Oncol·2009
8-other
Giant saphenous vein graft pseudoaneurysm rupture presenting with cardiac tamponade.
PMID 18242138·Heart Lung Circ·2009
5-case
Hypereosinophilic syndrome associated with multiple coronary aneurysms.
PMID 18164770·Int J Cardiol·2009
5-case
Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.
PMID 18665158·Mol Ther·2008
7-preclinical
Developing suicide prevention programs for African American youth in African American churches.
PMID 18611131·Suicide Life Threat Behav·2008
4-observational
Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model.
PMID 18802068·J Immunol·2008
7-preclinical
Potent in vitro and in vivo antitumor activity of interleukin-4-conjugated Pseudomonas exotoxin against human biliary tract carcinoma.
PMID 18798553·Int J Cancer·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE # J2-208
CLEVELAND, OH 44195 - Phone
- (216) 444-8050
Quick Facts
- NPI
- 1821570128
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile